Pharmacokinetics of N-acetylcysteine in man
- PMID: 3803419
- DOI: 10.1007/BF00606662
Pharmacokinetics of N-acetylcysteine in man
Abstract
N-Acetylcysteine was given intravenously and as three fast dissolving and one slow-release formulation, on separate occasions, as a single dose of 600 mg to 10 fasting (5 men and 5 women) healthy volunteers. Blood and urine were sampled for the following 12 h. Renal clearance constituted around 30% of total body clearance, which was 0.21 l/h/kg. Volume of distribution was 0.33 l/kg, consistent with distribution mainly to extracellular water. The late elimination half-life was 2.27 h and the mean residence time 1.62 h. The slow-release tablet resulted in a flattened plasma concentration-time curve typical of slow release formulations, while the other three oral formulations were rapidly absorbed. The oral availability of N-acetylcysteine varied between 6 and 10%, with the slow-release tablet having the lowest and the fast dissolving tablet the highest availability.
Similar articles
-
Pharmacokinetics and bioavailability of reduced and oxidized N-acetylcysteine.Eur J Clin Pharmacol. 1988;34(1):77-82. doi: 10.1007/BF01061422. Eur J Clin Pharmacol. 1988. PMID: 3360052 Clinical Trial.
-
Pharmacokinetics of hydroxy-3(S)-dihydroquinidine in healthy volunteers after intravenous and oral administration.Eur J Drug Metab Pharmacokinet. 1986 Jul-Sep;11(3):233-8. doi: 10.1007/BF03189851. Eur J Drug Metab Pharmacokinet. 1986. PMID: 3816879 Clinical Trial.
-
Pharmacokinetics of methylphenidate after oral administration of two modified-release formulations in healthy adults.Clin Pharmacokinet. 2003;42(4):393-401. doi: 10.2165/00003088-200342040-00007. Clin Pharmacokinet. 2003. PMID: 12648029 Clinical Trial.
-
The pharmacokinetics of a slow-release theophylline preparation in horses after intravenous and oral administration.Vet Res Commun. 1992;16(2):131-8. doi: 10.1007/BF01839010. Vet Res Commun. 1992. PMID: 1496815
-
Kinetics of cotinine after oral and intravenous administration to man.Eur J Clin Pharmacol. 1987;31(5):583-8. doi: 10.1007/BF00606635. Eur J Clin Pharmacol. 1987. PMID: 3830243
Cited by
-
Probenecid, an organic anion transporter 1 and 3 inhibitor, increases plasma and brain exposure of N-acetylcysteine.Xenobiotica. 2017 Apr;47(4):346-353. doi: 10.1080/00498254.2016.1187777. Epub 2016 Jun 9. Xenobiotica. 2017. PMID: 27278858 Free PMC article.
-
Acetylcysteine and Acetaminophen Overdose: The Many Shades of Gray.J Pediatr Pharmacol Ther. 2015 May-Jun;20(3):160-2. doi: 10.5863/1551-6776-20.3.160. J Pediatr Pharmacol Ther. 2015. PMID: 26170767 Free PMC article. No abstract available.
-
Effect of N-acetylcysteine on plasma cysteine and glutathione following paracetamol administration.Eur J Clin Pharmacol. 1989;36(2):127-31. doi: 10.1007/BF00609183. Eur J Clin Pharmacol. 1989. PMID: 2721538
-
Multiple-dose pharmacokinetics and pharmacodynamics of N-acetylcysteine in patients with end-stage renal disease.Clin J Am Soc Nephrol. 2010 Sep;5(9):1588-94. doi: 10.2215/CJN.00210110. Epub 2010 Jun 10. Clin J Am Soc Nephrol. 2010. PMID: 20538838 Free PMC article. Clinical Trial.
-
The Pharmacokinetic Profile and Bioavailability of Enteral N-Acetylcysteine in Intensive Care Unit.Medicina (Kaunas). 2021 Nov 8;57(11):1218. doi: 10.3390/medicina57111218. Medicina (Kaunas). 2021. PMID: 34833436 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources